[Neuroprotective properties of latanoprost].
Natalia Ivanovna KuryshevaPublished in: Vestnik oftalmologii (2022)
Glaucoma is the main cause of irreversible blindness in the world. Latanoprost - an ester prodrug of prostaglandin F 2α (PGF 2α ) - was the first prostaglandin analogue used to treat glaucoma. The review shows that latanoprost possesses direct neuroprotective properties such as blocking the entry of calcium ions into neurons and inhibiting the action of caspase-3, inhibiting the activity of cyclooxygenase and activation of polypeptide 2B1 (OATP2B1) and Klotho protein. It is emphasized that when the drug is instilled into the eye, the concentration of the drug inside the vitreous body is twice as high as what is required to ensure the survival of retinal ganglion cells.
Keyphrases
- induced apoptosis
- signaling pathway
- cerebral ischemia
- cell cycle arrest
- cell death
- endoplasmic reticulum stress
- optic nerve
- spinal cord
- oxidative stress
- adverse drug
- cancer therapy
- nitric oxide
- drug induced
- cataract surgery
- protein protein
- subarachnoid hemorrhage
- small molecule
- brain injury
- drug delivery
- electronic health record